2
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

What are the facts on cholesterol?

Questions physicians often ask about screening and treatment

Pages 51-59 | Published online: 17 May 2016

References

  • The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988: 148(1): 36–69
  • Schucker B, Wittes JT, Cutler JA, et al. Change in physician perspective on cholesterol and heart disease: results from two national surveys. JAMA 1987: 258(24): 3521–6
  • The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in incidence of coronary heart disease. JAMA 1984: 251(3): 351–64
  • The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to lowering cholesterol. JAMA 1984: 251(3): 365–74
  • Frick MH, Ho O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987: 317(20): 1237–45
  • Kannel WB, Castelli WP, Gordon T, et al. Serum cholesterol, lipoproteins, and die risk of coronary heart disease: the Framingham Study. Ann Intern Med 1971: 74(1): 1–12
  • Castelli WP, Wilson PW, Levy D, et al. Cardiovascular risk factors in the elderly. Am J Cardiol 1989: 63(16): 12H–9
  • Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986: 8(6): 1245–55
  • Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987: 257(23): 3233–40 [erratum, JAMA 1988; 259(18): 2698]
  • Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988: 223(5): 405–18
  • Griffin GC, Castelli WP. Good fat, bad fat: how to lower your cholesterol and beat the odds of a heart attack. Tucson: Fisher Books, 1989
  • Castelli WR, Griffin GC. How to help patients cut down on saturated fat: a simple strategy. Postgrad Med 1988: 84(3): 44–56
  • Berwick DM, Cretin S, Keeler EB. Cholesterol, children, and heart disease: an analysis of alternatives. New York: Oxford Univ Press, 1980
  • Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977: 62(5): 707–14
  • Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 1989: 321(19): 1311–6
  • Burke JJ 2d, Fischer PM. A clinician's guide to the office measurement of cholesterol. JAMA 1988: 259(23): 3444–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.